Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay

Ebolaviruses continue to pose a significant outbreak threat, and while Ebola virus (EBOV)-specific vaccines and antivirals have been licensed, efforts to develop candidates offering broad species cross-protection are continuing. The use of pseudotyped virus in place of live virus is recognised as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bentley, Emma M., Richardson, Samuel, Derveni, Mariliza, Rijal, Pramila, Townsend, Alain R., Heeney, Jonathan L., Mattiuzzo, Giada, Wright, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412100/
https://www.ncbi.nlm.nih.gov/pubmed/34449756
http://dx.doi.org/10.3390/tropicalmed6030155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412100/
https://www.ncbi.nlm.nih.gov/pubmed/34449756
http://dx.doi.org/10.3390/tropicalmed6030155

Ejemplares similares